Latest
industry research report on: Global Infection Control Market :
Industry Size, Share, Research, Reviews, Analysis, Strategies,
Demand, Growth, Segmentation, Parameters, Forecasts
Global Infection Control
Market in Cancer Therapy: Snapshot
The global infection
control market
in cancer therapy is prognosticated to register a healthy CAGR during
the course of the forecast period 2015–2023 while riding on a
surging level of cancer incidences worldwide. With the increasing
count of new cancer cases, scientists are feeling the urge to develop
more innovative and technologically advanced treatment procedures. As
a result, the demand in the market is forecasted to elevate at a
telling rate.
Some of the primary factors
that could be responsible for the aggressive growth of the global
infection control market in cancer therapy include the increasing
focus on the requirement of disinfection and sterilization, rising
aging population, growing count of surgical procedures, and improving
occurrence of hospital-acquired infections (HAIs). One in every 20
infections in the U.S. is an HAI, according to the U.S. Department of
Health and Human Services (HSS). Countries such as the U.K. and Japan
apart from the U.S. entertain favorable reimbursement policies, which
could be a good boost to the overall market.
Furthermore,
the rapidly growing global population is prophesied to set the tone
for a valuable growth in the global infection control market in
cancer therapy. As per the estimates of World Health Organization
(WHO), the worldwide elderly population could increase from close to
0.5 bn in 2010 to approximately 2.0 bn by 2050. Infection control and
prevention is key for both the doctors and cancer patients receiving
treatments. Thus, a perpetual growth could be expected in the market
for the coming years.
The
various types of treatment options that are commercially available in
the market for cancer include traditional surgery, chemotherapy,
radiation therapy, targeted therapy, immunotherapy, photodynamic
therapy, stem cell transplant therapy, etc. Among these
above-mentioned treatment options, the patients who are receiving
chemotherapy are more prone to get infections through their daily
activities. One out of every 10 patients who are treated with
chemotherapy gets an infection, which needs a hospital visit.
Microbes or microorganisms that enter into body of a cancer patient
usually acquire these infections and results in illness. The main
type of microorganisms causing these infections includes viruses,
bacteria, protozoa and some fungal organisms. The infections that are
developed in cancer patients can be more harmful than those
infections developed in healthy individuals.
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1352321
According to the Centers for
Disease Control and Prevention (CDC), it was estimated that
approximately 1.5 million new cases of cancer patients were diagnosed
in the United States in year 2010. With improvements in cancer
treatment therapies and number of geriatric population in the U.S.,
the total number of cancer patients is expect to increase in coming
years. Even though there is various advancements oncology treatment,
infections associated with these therapies remain a major cause of
mortality and morbidity in cancer patients. Several factors those are
responsible to developing infections in cancer patients including
immunosuppresion from their primary cancer and drug therapy
treatment. As cancer patients often require the placement of
intravascular devices as implanted ports to provide ease with drug
therapy infusion for linger period, there is chance of direct portal
entry of microorganisms in to the patient body. Thus, proper cancer
prevention practices are essential to minimize the risks and
complications associated with various cancer treatment therapies.
Some of the standard precautions to control the infections associated
with cancer therapy include usage of personal protective equipments,
hand hygiene procedures, injection safety, proper medication storage
and cleaning devices.
The infection control market in
cancer therapy is expected to have a huge growth potential in next
few years. The contributing factors behind such an assessment include
rise in base of geriatric population, increasing number of cancer
patients globally and advancements in cancer treatment technologies.
Additionally, growing healthcare awareness among the population and
poor sanitation conditions in underdeveloped countries further
expected to boost the market.
Geographically, North America
accounts for the largest share of the infection control market in
cancer therapy followed by the European region. The dominance of
North America in this market is seen due to rapidly aging population,
which can afford high cost cancer treatment and presence of various
market leaders that allows easy penetration in the North America
region. European infection control market in cancer therapy follows
the North America market due to extensive promotion and funding for
cancer treatment by the European government such as Germany and the
U.K. Asia-Pacific region is expected to witness fastest growth rate
in the near future due to rising population base and increasing
awareness about the cancer treatment.
Some of the major players
operating in this market includes 3M Healthcare Company, Advanced
Sterilization Products Services, Inc, Nordion, Inc., Steris
Corporation, Synergy Health, Plc, Getinge Group, Ahlstrom
Corporation, Honeywell International, Inc., Sakura Global Holding
Company, Kimberly Clark Corporation, Cisa S.P.A., Sterigenics
International, Inc. and others.
This research report analyzes
this market on the basis of its market segments, major geographies,
and current market trends. This report provides comprehensive
analysis of
Market growth drivers
Factors limiting market
growth
Current market trends
Market structure
Market projections for
upcoming years
This report is a complete study
of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It
includes analysis of recent developments in technology, Porter’s
five force model analysis and detailed profiles of top industry
players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with
detailed value chain analysis.
Reasons for Buying this
Report
This report provides
pin-point analysis for changing competitive dynamics
It provides a forward
looking perspective on different factors driving or restraining
market growth
It provides a six-year
forecast assessed on the basis of how the market is predicted to grow
It helps in understanding
the key product segments and their future
It provides pin point
analysis of changing competition dynamics and keeps you ahead of
competitors
It helps in making informed
business decisions by having complete insights of market and by
making in-depth analysis of market segments
It provides distinctive
graphics and exemplified SWOT analysis of major market segments
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment